About Michael Innes
Form D filings for Hemoshear Therapeutics in 2023 list Michael Innes as executive officer.
Michael Innes first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Michael Innes in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Michael Innes works with at each company, as listed on that company's latest Form D.
Hemoshear Therapeutics, Inc. · Form D, Nov 14, 2023
DF
David Friedman
Director
PH
Patrick Horn
Executive officer
BJ
Brian Johns
Executive officer
JT
John Tilton
Director
HI
H. Watkins III
Director
JI
John Brooks III
Director
KM
Kathleen Metters
Director
AH
Aric Holsinger
Chief Financial Officer
BW
Brian Warmhoff
Executive officer and director
RG
Robert Gould
Director